TrialNeurology2024

Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG Study

Carlo Antozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.